Biography
Jay Lessler concentrates his practice in domestic and foreign patent procurement, transactions involving intellectual property, client counseling, and patent litigation, primarily in the chemical, pharmaceutical, biotech, and computer software arts.
Jay works closely with inventors and in-house counsel to devise effective strategies to build and protect intellectual property assets.. His experience includes:
- all areas of patent prosecution involving domestic and foreign patents
- patent term extension proceedings
- licensing and joint development agreements
- purchase agreements
- material transfer agreements
- conducting due diligence investigations
- conducting validity and freedom-to-operate studies
- counseling clients in connection with the Hatch-Waxman Act and the Biologics Price Competition and Innovation Act
- preparation of Paragraph IV Notice letters and Offers for Confidential Access pursuant to the Hatch-Waxman Act
- counseling regarding the listability of patents in the FDA Orange Book
He also has significant ANDA, biotech, and trade secret litigation experience.
Jay was the co-chair of Practising Law Institute’s (“PLI’s”) annual Advanced Patent Prosecution Workshop from 2006 through 2021.
News & Views
-
Speaking Engagement
Obviousness, Obviousness-Type Double Patenting (“OTDP”), and Inherent Obviousness: Practice Notes for Patent Applications
ACI’s 20th Advanced Summit on Life Sciences Patents -
Deal
Blank Rome Represents Heraeus Holding in Medical Technology Acquisitions
Peter Schnur, Thomas A. Cournoyer, Maria Trainor, Adam R. Seiden, Naomi M. Gallimore, Jason A. Snyderman
-
Alert
Supreme Court Sets Limits for Assignor Estoppel
Intellectual Property & Technology -
Blog Post
What Could a DHHS Secretary Becerra Mean for the Pharmaceutical Industry?
Government Contracts Navigator -
Alert
New Fast-Track Appeals Pilot Program for U.S. Patent Applications
Intellectual Property & Technology -
Alert
Special Exemptions from Product and Patent Liability for COVID-19 Countermeasures
Product Liability and Intellectual Property -
Blog Post
After Acetris Decision, Trade Agreements Act Compliance Questions Abound: Contractors Need Guidance
Government Contracts Navigator -
Blog Post
Federal Circuit Holds Generic Drugs Manufactured in the U.S. from API Produced in India Qualify for Sale to U.S. under Trade Agreements Act (Acetris Decision)
Government Contracts Navigator -
Article
Ensuring Section 121 Safe Harbor Applies to Patent
Law360 -
Event
Advanced Patent Prosecution Workshop 2011: Claim Drafting and Amendment Writing
Practicing Law Institute
Affiliations
Memberships
- American Chemical Society
- American Intellectual Property Law Association
- New York Intellectual Property Law Association
Credentials
Admissions
- Pennsylvania
- New Jersey
- New York
- U.S. Patent and Trademark Office
Education
- Columbia University, BS
- Fordham University School of Law, JD
- New York University, MS